SELFSELF Facebook ad: “Tori Spelling shares tips for caring for her…”
Ran for 7 days, from June 11 to June 17, 2026, the last day Crush saw it.
Run by SELF on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 979838324885616
- Platforms
- Relaunches
- 8
Ad text
Tori Spelling shares tips for caring for her daughter with mild to moderate eczema (atopic dermatitis) and seborrheic dermatitis (seb derm), along with her experience using ZORYVE (roflumilast) cream 0.15% for eczema and ZORYVE (roflumilast) topical foam 0.3% for seb derm. Approved Uses ZORYVE (roflumilast) cream 0.15% is a prescription medicine used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in adults and children 6 years of age and older. It is not known if ZORYVE cream 0.15% is safe and effective in children with mild to moderate eczema (atopic dermatitis) under 6 years of age. ZORYVE foam is a prescription medicine used on the skin (topical) to treat seborrheic dermatitis in adults and children 9 years of age and older. It is not known if ZORYVE foam is safe and effective in children with seborrheic dermatitis under 9 years of age. IMPORTANT SAFETY INFORMATION ZORYVE is for use on the skin (topical use) only. Do not use ZORYVE in or on your eyes, mouth, or vagina. Do not use ZORYVE if you have certain liver problems. Before using ZORYVE, tell your healthcare provider about all of your medical conditions, including if you: • have liver problems. • are pregnant or plan to become pregnant. It is not known if ZORYVE will harm your unborn baby. • are breastfeeding or plan to breastfeed. It is not known if ZORYVE passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with ZORYVE. Breastfeeding women using ZORYVE should use it on the smallest area of the skin and for the shortest time needed. Do not apply ZORYVE directly to the nipple or areola to avoid contact with your baby. Avoid direct skin contact of treated areas with your baby if ZORYVE is applied to your chest. Tell your healthcare provider about the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What should I avoid while using ZORYVE foam? ZORYVE foam is flammable. Avoid fire, flame, and smoking during and right after you apply ZORYVE. The most common side effects of ZORYVE cream 0.15% in adult and children 6 years of age and older treated for atopic dermatitis include: • headache • nausea • application site pain • diarrhea • vomiting The most common side effects of ZORYVE foam 0.3% in people treated for seborrheic dermatitis include: • common cold • nausea • headache These are not all of the possible side effects of ZORYVE. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Please see Patient Information for ZORYVE through the link in the post copy, by visiting or clicking our bio @zoryve_roflumilast, or by visiting ZORYVE.com. For US audiences only. Talk to your doctor to see if ZORYVE cream 0.15% for mild to moderate eczema (age 6+) or ZORYVE foam for seborrheic dermatitis (age 9+) is right for you. #TeamZORYVE #ZORYVEPartner #PaidSpokesperson © 2026 Arcutis Biotherapeutics, Inc. All rights reserved. US-COM-PTF-00972 06/26.
Where the ad sends people
self.com
SELF
Open the advertiser's link: self.com(opens in a new tab)
